An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis.
Wang X, Zhang Y, Jin Y, Dai L, Yue Y, Hu J, Liu X, Pang K, Ye S, Chen Y, Ye W, Shi X, Ma X, Guo L, Liu Y, Ta N, Zhu X, Lin L, Wang J, Yan R, Wang P, Song X, Zhou Y, Zhou L, Wang Q, Guan T, Li T, Zhou L, Pan W, He Y, Wu X, Xu Y, Yang L, Xu H.
Wang X, et al. Among authors: li t.
Cell. 2025 Jun 16:S0092-8674(25)00625-7. doi: 10.1016/j.cell.2025.05.038. Online ahead of print.
Cell. 2025.
PMID: 40562027